| DB ID | MyCo_2462 |
| Title | Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients |
| Year | 2002 |
| PMID | 12402199 |
| Fungal Diseases involved | Invasive aspergillosis |
| Associated Medical Condition | Allogeneic Stem Cell Transplant Recipients |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | The ethics committee of Gasthuisberg University Hospital approved the study protocol. |
| Site of Infection | None |
| Opportunistic invasive | Invasive |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | GM |
| Biomarker Full Name | Galactomannan |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Belgium |
| Cohort | 100 allogeneic stem cell transplant recipients included in the study. |
| Cohort No. | 100 |
| Age Group | 17–58 |
| P Value | None |
| Sensitivity | 0.944 |
| Specificity | 0.988 |
| Positive Predictive Value | 0.944 |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | ELISA Kit- Platelia Aspergillus (Platelia Aspergillus EIA, Bio-Rad). |
| Assay Data | None |
| Validation Techniques used | FDA Approved -Platelia Aspergillus ELISA |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
